Published in Am J Pathol on March 26, 2010
New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol (2011) 3.97
How tough is brittle bone? Investigating osteogenesis imperfecta in mouse bone. J Bone Miner Res (2014) 1.00
Diverse osteoclastogenesis of bone marrow from mandible versus long bone. J Periodontol (2013) 0.80
Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta. Stem Cells Dev (2013) 0.79
Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α. Osteoporos Int (2016) 0.78
Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice. Osteoporos Int (2015) 0.76
1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption. BMC Musculoskelet Disord (2014) 0.75
Counteracting bone fragility with human amniotic mesenchymal stem cells. Sci Rep (2016) 0.75
Visual reporters for study of the osteoblast lineage. Bone (2016) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells (2001) 6.86
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest (2000) 5.78
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem (2007) 4.74
The molecular understanding of osteoclast differentiation. Bone (2006) 4.39
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res (2000) 3.38
Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res (2002) 3.21
Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res (2001) 2.37
NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem (2007) 2.22
Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc Natl Acad Sci U S A (1975) 2.20
Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A (1993) 2.07
Bone stem cells. J Cell Biochem Suppl (1998) 2.02
Histological analysis of GFP expression in murine bone. J Histochem Cytochem (2005) 1.87
Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem (2005) 1.83
M-CSF mediates TNF-induced inflammatory osteolysis. J Clin Invest (2005) 1.64
Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol (2004) 1.50
Regulation of osteoclast differentiation. Ann N Y Acad Sci (2006) 1.49
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone (2000) 1.46
Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res (2004) 1.36
Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res (2001) 1.35
Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors. J Bone Miner Res (2008) 1.12
Increased bone turnover with decreased bone formation by osteoblasts in children with osteogenesis imperfecta tarda. Pediatr Res (1983) 1.03
Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology (2002) 1.00
PCR genotyping of oim mutant mice. Biotechniques (1996) 0.93
Marrow stromal fibroblasts. Calcif Tissue Int (1995) 0.88
Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta. J Cell Biochem (2007) 0.85
Mechanisms of compensation of hemolytic anemia in a lactate dehydrogenase mouse mutant. Exp Hematol (1987) 0.80
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature (2008) 6.61
Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood (2004) 4.56
Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology (2002) 4.13
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis (2003) 4.03
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol (2005) 3.74
Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol (2007) 3.58
Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab (2006) 3.57
The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J Biol Chem (2006) 3.04
Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol (2005) 3.00
Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol (2003) 2.82
The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol (2004) 2.68
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol (2005) 2.29
Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae. J Virol (2008) 2.24
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med (2005) 2.21
Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr (2004) 2.20
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet (2005) 2.10
Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab (2010) 2.05
Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog (2010) 2.02
Identification of differentially expressed genes between osteoblasts and osteocytes. Bone (2009) 1.97
Histological analysis of GFP expression in murine bone. J Histochem Cytochem (2005) 1.87
Gastroenteritis in US Marines during Operation Iraqi Freedom. Clin Infect Dis (2005) 1.86
Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr (2005) 1.84
Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem (2005) 1.83
Structural basis for the receptor binding specificity of Norwalk virus. J Virol (2008) 1.82
Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol (2008) 1.81
DICCCOL: dense individualized and common connectivity-based cortical landmarks. Cereb Cortex (2012) 1.78
Identification of multiple osteoclast precursor populations in murine bone marrow. J Bone Miner Res (2005) 1.75
Noroviral P particle: structure, function and applications in virus-host interaction. Virology (2008) 1.75
Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol (2011) 1.73
Analysis of αSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing. J Bone Miner Res (2014) 1.66
E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J Med Virol (2004) 1.64
Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect Genet Evol (2004) 1.62
Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone (2008) 1.59
Norovirus-host interaction: implications for disease control and prevention. Expert Rev Mol Med (2007) 1.57
Dentin matrix protein 1 gene cis-regulation: use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo. J Biol Chem (2005) 1.57
MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primates. PLoS Biol (2011) 1.57
Widespread expression of piRNA-like molecules in somatic tissues. Nucleic Acids Res (2011) 1.56
Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology (2008) 1.54
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun (2012) 1.49
Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol (2010) 1.46
C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. J Virol (2006) 1.45
In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells (2012) 1.44
Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2007) 1.44
Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes. Biotechnol Prog (2006) 1.43
Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One (2009) 1.42
Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40
Seroprevalence of noroviruses in swine. J Clin Microbiol (2005) 1.39
Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol (2010) 1.39
Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res (2003) 1.39
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol (2012) 1.38
Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis (2012) 1.38
Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology (2003) 1.37
Second harmonic generation imaging microscopy studies of osteogenesis imperfecta. J Biomed Opt (2007) 1.37
Comparison of the action of transient and continuous PTH on primary osteoblast cultures expressing differentiation stage-specific GFP. J Bone Miner Res (2004) 1.36
Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res (2011) 1.35
Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma. PLoS One (2013) 1.34
Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood (2005) 1.32
Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog (2011) 1.31
PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood (2012) 1.30
Detection of viral agents in fecal specimens of monkeys with diarrhea. J Med Primatol (2007) 1.29
Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques. Genome Res (2012) 1.27
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol (2004) 1.27
T lymphocyte-deficient mice lose trabecular bone mass with ovariectomy. J Bone Miner Res (2006) 1.26
Homologous versus heterologous immune responses to Norwalk-like viruses among crew members after acute gastroenteritis outbreaks on 2 US Navy vessels. J Infect Dis (2002) 1.26
Cryo-EM structure of a novel calicivirus, Tulane virus. PLoS One (2013) 1.26
Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles. Virology (2010) 1.25
Ebf1-dependent control of the osteoblast and adipocyte lineages. Bone (2008) 1.23
Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. J Pediatr (2011) 1.21
TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci U S A (2013) 1.19
Axonal fiber terminations concentrate on gyri. Cereb Cortex (2011) 1.18
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol (2012) 1.18
Association of coagulation activation with clinical complications in sickle cell disease. PLoS One (2012) 1.17
Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol (2014) 1.15
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. J Clin Oncol (2013) 1.15
Generation and characterization of Col10a1-mcherry reporter mice. Genesis (2011) 1.12
Long bone fracture repair in mice harboring GFP reporters for cells within the osteoblastic lineage. J Orthop Res (2010) 1.11
Recovery of infectious virus by transfection of in vitro-generated RNA from tulane calicivirus cDNA. J Virol (2008) 1.10
Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS One (2013) 1.10
A rapid, nonradioactive in situ hybridization technique for use on cryosectioned adult mouse bone. Calcif Tissue Int (2008) 1.10
Norovirus recognizes histo-blood group antigens on gastrointestinal cells of clams, mussels, and oysters: a possible mechanism of bioaccumulation. J Food Prot (2007) 1.10
Development of an enzyme immunoassay for detection of sapovirus-specific antibodies and its application in a study of seroprevalence in children. J Clin Microbiol (2006) 1.10
Emergence of the GII4/2006b variant and recombinant noroviruses in China. J Med Virol (2008) 1.10
Norovirus gastroenteritis, increased understanding and future antiviral options. Curr Opin Investig Drugs (2008) 1.09
Human caliciviruses and pediatric gastroenteritis. Semin Pediatr Infect Dis (2004) 1.08
Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J Cell Biochem (2003) 1.06